Form 4: Danaher SVP Gray Receives Equity Grant

Danaher's SVP of Strategic Development, R. Bradley Gray, was granted 2,849 restricted stock units and 7,699 stock options on March 1, 2026.

Summary

• R. Bradley Gray, SVP Strategic Development at Danaher Corp, was granted 2,849 restricted stock units (RSUs) on March 1, 2026.
• The RSUs are payable solely in common stock and will vest 25% on each of the first four anniversaries of the grant date, starting March 1, 2027.
• Gray also received 7,699 employee stock options with an exercise price of $210.64 on March 1, 2026.
• Fifty percent of these options will become exercisable on the third anniversary (March 1, 2029) and the remaining fifty percent on the fourth anniversary (March 1, 2030) of the grant date.
• The stock options have an expiration date of March 1, 2036.
• Following these transactions, Gray directly beneficially owns 14,463 shares of common stock and 7,699 derivative securities (stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder interests, without indicating any unusual or concerning activity.

Positives

• The equity grants align the interests of R. Bradley Gray, a key executive, with those of shareholders, incentivizing long-term company performance.
• The grants are a standard component of executive compensation, reflecting ongoing commitment to retaining and motivating senior leadership.

Future Outlook

The future outlook for R. Bradley Gray's equity holdings includes the vesting of 2,849 restricted stock units in 25% increments annually over the next four years, starting March 1, 2027. Additionally, 7,699 stock options will become exercisable in two equal tranches on March 1, 2029, and March 1, 2030, with an ultimate expiration date of March 1, 2036.

Industry Context

StockSavvy.ai notes that the granting of restricted stock units and stock options is a standard and widely adopted practice in executive compensation across various industries, including the diversified industrial sector where Danaher operates. This approach is designed to align executive incentives with long-term shareholder value creation and retention.

Comparison to Industry Standards

• The use of RSUs and stock options as a significant component of executive compensation is consistent with practices observed in leading global companies, particularly in the life sciences and diagnostics industries where Danaher has a strong presence.
• The vesting schedule of 25% annually for RSUs over four years is a common structure aimed at promoting long-term retention and performance.
• The option exercisability schedule (50% on the third and fourth anniversaries) is also a typical structure, often seen in companies like Thermo Fisher Scientific or Abbott Laboratories, designed to reward sustained performance over several years.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants are intended to align the interests of a key executive with shareholders, potentially leading to improved long-term performance and value creation.
• Employees: Standard executive compensation practices can set a precedent for broader employee incentive programs, though this filing specifically pertains to a senior officer.

Next Steps

• Vesting of 25% of the granted RSUs on March 1, 2027, and annually thereafter for three more years.
• 50% of the granted stock options becoming exercisable on March 1, 2029.
• The remaining 50% of the granted stock options becoming exercisable on March 1, 2030.

Key Dates

Keywords

Danaher, DHR, Insider Transaction, Form 4, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, R. Bradley Gray